Advertisement
A. E. Bennett award paper| Volume 21, ISSUE 4, P341-365, April 1986

Download started.

Ok

Cerebrospinal fluid somatostatin and psychiatric illness

  • David R. Rubinow
    Correspondence
    Address reprint requests to Dr. David R. Rubinow, Unit on Peptide Studies, Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20205.
    Affiliations
    From the Unit on Peptide Studies, Biological Psychiatry Branch, NIMH, Bethesda, MDUSA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Somatostatin is a tetradecapeptide that is assuming increasing importance as a regulator of central nervous system activity. Originally identified as the hypothalamic growth hormone release-inhibiting factor, somatostatin has subsequently been shown to be extensively and selectively distributed throughout the central nervous system, to alter neuron excitability, to regulate and be regulated by the activity of classical neurotransmitters and neuropeptides, to exert a number of direct behavioral actions, and to display neuropsychiatric disorder-related alterations. In this article, a three-part study of cerebral spinal fluid (CSF) somatostatin in affective illness and schizophrenia is presented. In part 1, significant reductions in CSF somatostatin were observed in 49 bipolar and unipolar depressed patients relative to 47 controls. Values during depression were also significantly lower than those observed in affective disorder during the improved state or in schizophrenia. Diurnal studies involving paired am and pm lumbar punctures revealed that depressed patients and normal volunteers had similar somatostatin values in the evening, despite having significantly different values in the morning. In part 2, the effects of several psychopharmacological agents on CSF somatostatin were examined, particularly the tricyclic anticonvulsant carbamazepine. A significant reduction of CSF somatostatin during treatment with carbamazepine was observed. The effect of carbamazepine on somatostatin could be related to its anticonvulsant, analgesic, or psychotropic effects. Part 3 deals with somatostatin as a major regulator of hypothalamic-pituitary-adrenal (HPA) axis activity. Somatostatin affects HPA activity by inhibiting, at a number of cellular levels, the stimulated release of adrenocorticotrophic hormone (ACTH) from the pituitary. A significant negative relationship between CSF somatostatin and the postdexamethasone plasma cortisol level in 22 depressed and 16 schizophrenic patients was observed. This relationship between low CSF somatostatin and escape from dexamethasone suppression was observed irrespective of diagnosis (i.e., depression or schizophrenia). Thus, there is indirect supporting evidence for a role for somatostatin dysregulation in the most consistently observed biological abnormality in depression, escape from dexamethasone suppression. Further study of somatostatin in neuropsychiatric disorders, and particularly depressive illness, offers great promise for better understanding their underlying affective, vegetative, cognitive, and physiological dysregulations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Agren H
        • Lundqvist G
        Low levels of somatostatin in human CSF mark depressive episodes.
        Psychoneuroendocrinology. 1984; 9: 233-248
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        ed 3. APA, Washington, DC1981
        • Aponte G
        • Leung P
        • Gross D
        • Yamada T
        Effects of somatostatin on food intake in rats.
        Life Sci. 1984; 35: 741-746
        • Arnold MA
        • Reppert SM
        • Rorstad OP
        • Sagar SM
        • Keutman HT
        • Perlow MJ
        • Martin JB
        Temporal patterns of somatostatin in the cerebrospinal fluid of the rhesus monkey: Effect of environmental lighting.
        J Neurosci. 1982; 2: 674-680
        • Beal MF
        • Martin JB
        Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity.
        Neurosci Lett. 1984; 47: 125-130
        • Beal MF
        • Martin JB
        Somatostatin: Normal and abnormal observations in the central nervous system.
        in: Wurthman RJ Corkin S Girowdon J Alzheimer's Disease: Advances in Brain Research and Therapies. Center for Brain Sciences and Metabolism Trust, Boston1984: 229-259
        • Beal MF
        • Bird ED
        • Langlais PJ
        • Martin JB
        Somatostatin is increased in the nucleus accumbens in Huntington's disease.
        Neurology. 1984; 34: 663-666
        • Bentsen KD
        • Gram L
        • Veje A
        Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate.
        Acta Neurol Scand. 1983; 67: 235-241
        • Berelowitz M
        • Perlow MJ
        • Hoffman HJ
        • Frohman LA
        The diurnal variation of immunoreactive thyrotropin-releasing hormone and somatostatin in the cerebrospinal fluid of the rhesus monkey.
        Endocrinology. 1981; 109: 2102-2109
        • Bernasconi R
        • Martin P
        Effects of antileptic drugs on the GABA turnover rate.
        Naunyn Schmiedeberg Arch Pharmacol. 1979; 307 (abstr 251).: R63
        • Berrettini WB
        • Nurnberger J
        • Nadi NS
        • Simmons-Alling S
        • Gershon ES
        CSF studies in euthymic bipolar patients.
        in: Scientific Program for the 38th Annual Convention of the Society for Biological Psychiatry. SBP, New York1983: 83 (abstr 49).
        • Berrettini WH
        • Post RM
        GABA in affective illness.
        in: Neurobiology of Mood Disorders. Vol 1. Williams & Wilkins, Baltimore1984: 673-685
        • Bissette G
        • Walleus H
        • Widerlov E
        • Karlsson I
        • Eklundt K
        • Loosen PT
        • Nemeroff CB
        Reductions of cerebrospinal fluid concentrations of somatostatin-like immunoreactivity (SRIF LI) in dementia, major depression and schizophrenia.
        in: Abstracts of the 14th Annual Meeting of the Society for Neuroscience. Vol 10. 1984: 1093 (abstr 319.11).
        • Black PM
        • Ballantine HT
        • Carr DB
        • Beal MF
        • Martin JB
        Beta-endorphin and somatostatin concentrations in the cerebrospinal fluid of patients with depressive disorder.
        in: 39th Annual Convention of the Society of Biological Psychiatry. 1984: 177 (abstr 135).
        • Brazeau P
        • Vale W
        • Burgus R
        • Ling N
        • Butcher M
        • Rivier J
        • Guillemin R
        Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.
        Science. 1973; 197: 77-79
        • Brown M
        • Vale W
        Central neurvous system effects of hypothalamic peptides.
        Endocrinology. 1975; 96: 1333-1336
        • Brown MR
        • Rivier C
        • Vale W
        Central nervous system regulation of adrenocorticotropin secretion: Role of somatostatins.
        Endocrinology. 1984; 114: 1546-1549
        • Brownstein M
        • Arimura A
        • Stao H
        • Schally AV
        • Kizer JS
        The regional distribution of somatostatin in the rat brain.
        Endocrinology. 1975; 96: 1456-1461
        • Bunney Jr, WE
        • Hamburg DA
        Methods for reliable longitudinal observation of behavior. Development of a method for systematic observation of emotional behavior on psychiatric wards.
        Arch Gen Psychiatry. 1963; 9: 280-294
        • Carroll BJ
        The dexamethasone suppression test for melancholia.
        Br J Psychiatry. 1982; 140: 292-304
        • Carroll BJ
        • Curtis GC
        • Davies BM
        • Mendels J
        • Sugerman AA
        Urinary free cortisol excretion in depression.
        J Psychol Med. 1976; 6: 43-50
        • Carroll BJ
        • Curtis GC
        • Mendels J
        Neuroendocrine regulation in depression. 1. Limbic system—adrenocortical dysfunction.
        Arch Gen Psychiatry. 1976; 33: 1039-1044
        • Chihara K
        • Arimura A
        • Schally A
        Effect of intraventricular injection of dopamine, nor epinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyscal portal blood.
        Endocrinology. 1979; 104: 1656-1662
        • Cohen N
        • Rosing E
        • Wiley K
        • Slater P
        Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle.
        Life Sci. 1978; 23: 1659-1664
        • Consolo S
        • Bianchi S
        • Ladinsky H
        Effect of carbamazepine on cholinergic parameters in rat brain areas.
        Neuropharmacology. 1976; 15: 653-677
        • Cramer H
        • Kohler J
        • Oepen G
        • Schomburg G
        • Schrotev E
        Huntington's chorea—Measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.
        J Neurol. 1981; 225: 183
        • Davies P
        Neurotransmitters in Alzheimer's disease.
        in: Read before the International Study Group on the Pharmacology of Memory Disorders Associated with Aging, Zurich, April 11981
        • Davies P
        • Terry RD
        Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
        Neurobiology. 1981; 2: 9-14
        • Delfs JF
        • Dichter MA
        Effects of somatostatin on mammalian cortical neurons in culture: Physiological actions and unusual dose response characteristics.
        J Neurosci. 1983; 3: 1176-1188
        • Delfs JR
        • Zhu C-H
        • Dichter MA
        Coexistence of acetylcholinesterase and somatostatin immunoreactivity in neurons cultured from rat cerebrum.
        Science. 1984; 223: 61-63
        • Dewan M
        • Pandurangi AK
        • Boucher ML
        • Levy BF
        • Major LF
        Abnormal dexamethasone suppression test results in chronic schizophrenic patients.
        Am J Psychiatry. 1982; 139: 1501-1503
        • Dierickx K
        • Vandesande F
        Immunocytochemical localization of somatostatin-containing neurons in the rat hypothalamus.
        Cell Tissue Res. 1979; 201: 349-359
        • Dodd J
        • Kelly JS
        Is somatostatin an excitatory transmitter in the hippocampus?.
        Nature. 1978; 273: 674-675
        • Doran A
        • Rubinow DR
        • Roy A
        • Pickar D
        CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
        Arch Gen Psychiatry. 1986; (in press.)
        • Dupont E
        • Christensen SE
        • Hansen AP
        • Olivarius B deF
        • Orskov H
        Low cerebrospinal fluid somatostatin in Parkinson's Disease: An irreversible abnormality.
        Neurology. 1982; 32: 312-314
        • Efendic S
        • Luft R
        Somatostatin: A classical hormone, a locally active polypeptide, and a neurotransmitter.
        Ann Clin Res. 1980; 12: 87-94
        • Elde RP
        • Hokfelt T
        • Johansson O
        • Efendic S
        • Luft R
        Somatostatin-containing pathways in the nervous system.
        Neuroscience. 1976; 2 (abstr 1084).: 759
        • Epelbaum J
        • Willoughby JO
        • Brazeau P
        • Martin JB
        The effects of brain lesions and hypothalamic deafferentation on somatostatin distribution in the rat brain.
        Endocrinology. 1977; 101: 1495-1502
        • Epelbaum J
        • Brazeau P
        • Tsang D
        • Brawer J
        • Martin JB
        Subcellular distribution of radioimmunoassayable somatostatin in rat brain.
        Brain Res. 1977; 126: 309-323
        • Ferrier IN
        • Cross AJ
        • Johnson JA
        • Roberts GW
        • Crow TJ
        • Corsellis JA
        • Lee YC
        • O'Shaughnessy D
        • Adrian TE
        • McGregor GP
        • Baracese-Hamilton AJ
        • Bloom SR
        Neuropeptides in Alzheimer type dementia.
        J Neurol Sci. 1983; 62: 159-170
        • Finklestein S
        • Benowitz LI
        • Baldessarini RJ
        • Arana GW
        • Levine D
        • Woo E
        • Bear D
        • Moya K
        • Stoll AL
        Mood, vegetative disturbance, and dexamethasone suppression test after stroke.
        Ann Neurol. 1982; 12: 463-468
        • Finley JCW
        • Maderdrut JL
        • Roger LJ
        • Petrusz P
        The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system.
        Neuroscience. 1981; 6: 2173-2192
        • Garcia-Sevilla J
        • Magnusson T
        • Carlsson A
        Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover.
        Brain Res. 1978; 155: 159-164
        • Gerner RH
        • Gwirtsman HE
        Abnormalities of dexamethasone suppression test and urinary MHPG in anorexia nervosa.
        Am J Psychiatry. 1981; 138: 650-653
        • Gerner RH
        • Yamada T
        Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients.
        Brain Res. 1982; 238: 298-302
        • Gibbons JL
        Cortisol secretion rates in depressive illness.
        Arch Gen Psychiatry. 1964; 10: 572-575
        • Gothert N
        Somatostatin selectively inhibits noradrenaline release from hypothalamic neurons.
        Nature. 1980; 288: 86-88
        • Graham PM
        • Booth J
        • Boranga G
        • Galhenage S
        • Myers CM
        • Tech CK
        • Cox LS
        The dexamethasone suppression test in mania.
        J Affective Disord. 1982; 4: 201-211
        • Havlicek V
        • Rezek M
        • Friesen H
        Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system.
        Pharmacol Biochem Behav. 1976; 5: 73-77
        • Havlicek V
        • Rezek M
        • Leybin L
        • Friesen H
        Analgesic effect of cerebral ventricular administration of somatostatin (SRIF).
        in: Fed Proc. 36. 1977: 363
        • Heisler S
        • Reisine T
        • Hook V
        • Axelrod J
        Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and adrenocorticotropin secretion in mouse pituitary tumor cells.
        in: Proc Natl Acad Sci USA. 79. 1982: 6502-6507
        • Higuchi T
        • Sikand GS
        • Kato N
        • Wada JA
        • Friesen HG
        Profound suppression of kindled seizures by cysteamine: Possible role of somatostatin to kindled seizures.
        Brain Res. 1983; 288: 359-362
        • Higuchi T
        Neuropeptides and amygdaloid kindling.
        in: Wada JA Kindling III. Raven Press, New York1985 (in press.)
        • Hokfelt T
        • Elfvin LG
        • Elde R
        • Schultzberg M
        • Goldstein M
        • Luft R
        Occurrence of somatostatin immunoreactivity in some peripheral sympathetic noradrenergic neurons.
        in: Proc Natl Acad Sci USA. 74. 1977: 3587-3591
        • Hokfelt T
        • Johansson O
        • Ljungdahl A
        • Lundberg JM
        • Schultzberg M
        Peptidergic neurons.
        Nature. 1980; 264: 515-521
        • Ioffe S
        • Havlicek V
        • Friesen H
        • Chernick V
        The excitatory effect of iontophoretically applied somatostatin (SRIF) in cortical neurons in awake unanesthetized animals.
        in: Fed Proc. 36. 1977: 364
        • Iversen LL
        • Iversen SD
        • Bloom F
        • Douglas C
        • Brown M
        • Vale W
        Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro.
        Nature. 1978; 273: 161-163
        • Jeftinija S
        • Randic M
        Somatostatin and glutamic acid increase excitability of single cuta neous primary afferent C- and A(delta)-fibers in the cat spinal cord.
        in: Abstracts of 11th Annual Meeting of the Society for Neuroscience. Society for Neuroscience, Los Angeles1981: 437 (abstr 140.3).
        • Jimerson DC
        • Insel TR
        • Reus VI
        • Kopin IJ
        Increased plasma MHPG in dexamethasoneresistant depressed patients.
        Arch Gen Psychiatry. 1983; 40: 173-176
        • Johannson O
        • Hokfelt T
        Thyrotropin releasing hormone, somatostatin and enkephalin: Distribution studies using immunohistochemical techniques.
        J Histochem Cytochem. 1980; 28: 364-366
        • Kato N
        • Higuchi T
        • Friesen HG
        • Wada JA
        Changes of immunoreactive somatostatin and B-endorphin content in rat brain after amygdaloid kindling.
        Life Sci. 1983; 32: 2415-2422
        • Kessler JA
        • Adler JE
        • Black IB
        Substance P and somatostatin regulate sympathetic nor adrenergic function.
        Science. 1983; 221: 1059-1061
        • Knigge KM
        • Bennett-Clarke C
        • Burchanowski B
        • Joseph SA
        • Romagnano MA
        • Sternberger LA
        Relationships of some releasing-hormone-producing neuron systems to the ventricles of the brain.
        in: Motta M Endocrine Functions of the Brain. Raven, New York1980: 195-206
        • Leitner JW
        • Rifkin RM
        • Maman A
        • Sussman KE
        Somatostatin binding to pituitary plasma membranes.
        Biochem Biophys Res Commun. 1979; 87: 919-927
        • Leroux P
        • Pelletier G
        Radioautographic localization of somatostatin-14 and somatostatin 28 binding sites in the rat brain.
        Peptides. 1984; 5: 503-506
        • Lotter EC
        • Woods S.C.
        Somatostatin decreases food intake.
        Diabetes. 1977; 26: 358
        • Low M.J.
        • Hammer R.E.
        • Goodman R.H.
        • Habener J.F.
        • Palmiter R.
        • Brinster R.
        Tissue specific post-translational processing of rat pre-pro-somatostatin encoded by a metallothionein-somatostatin fusion gene expressed in transgenic mice.
        Cell. 1985; (in press).
        • Luft R.
        • Efendic S.
        • Hokfelt T.
        • Johansson O.
        • Arimura A.
        Immunohistochemical evidence for the localization of somatostatin-like immunoreactivity in a cell population of pancreatic islets.
        Med Biol. 1974; 52: 423-430
        • Luft R.
        • Efendic S.
        • Hokfelt T.
        Somatostatin—Both hormone and neurotransmitter?.
        Diabetologia. 1978; 14: 1-13
        • Lundqvist G.
        • Gustavsson S.
        • Elide R.
        • Arimura A.
        A radioimmunosorbent assay for plasma somatostatin.
        Clin Chim Acta. 1980; 101: 183-191
        • Marks N.
        • Stern F.
        inactivation of somatostatin (GH-RIH) and its analogs by crude and partially purified rat brain extracts.
        FEBS Lett. 1975; 55: 220-224
        • Matthe-Sorenssen D.
        • Wood P.L.
        • Cheney D.L.
        • Costa H.
        Modulation of the turnover rate of acetylcholine in rat brain by intraventricular injections of thyrotropin-releasing hormone, somatostatin, neurotensin and angiotensin II.
        J Neurochem. 1978; 31: 685-691
        • Negro-Vilar A.
        • Ojeda S.R.
        • Arimura A.
        • McCann S.
        Dopamine and norepinephrine stimulate somatostatin release by median eminence fragments in vitro.
        Life Sci. 1978; 23: 1493-1498
        • Nemeroff C.B.
        • Youngblood W.W.
        • Manberg P.J.
        • Prange A.J.
        • Kizer J.S.
        Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
        Science. 1983; 221: 972-975
        • Nemeroff C.B.
        • Bissette G.
        • Busby W.H.
        • Youngblood W.W.
        • Rossor M.
        • Roth M.
        • Kizer J.S.
        Regional brain concentrations of neurotensin, thyrotropin releasing hormone and somatostatin in Alzheimer's disease.
        Neurosci Abstr. 1983; 9: 1052
        • Olpe H.R.
        • Balcar V.J.
        • Bittiger H.
        • Ring K.
        • Sieber P.
        Central actions of somatostatin.
        Eur J Pharmacol. 1980; 63: 127-133
        • Oran J.J.
        • Edwardson J.
        • Millard P.H.
        Investigation of cerebrospinal fluid neuropeptides in idiopathic senile dementia.
        Gerontology. 1981; 27: 216-223
        • Pace C.S.
        • Tarvin J.T.
        Somatostatin: Mechanism of action in pancreatic islet B-cells.
        Diabetes. 1981; 30: 836-842
        • Palkovits M.
        • Tapia-Arancibia L.
        • Kordon C.
        • Epelbaum J.
        Somatostatin connections between the hypothalamus and the limbic system of the rat brain.
        Brain Res. 1982; 250: 223-228
        • Palmer G.C.
        • Jones D.J.
        • Medina M.A.
        • Stavinoha W.B.
        Anticonvulsant drug actions on in vitro and in vivo levels of cyclic AMP in the mouse brain.
        Epilepsia. 1979; 20: 95-104
        • Patel Y.C.
        • Reichlin S.
        Somatostatin.
        in: Jaffe B.M. Beheman H.R. Methods of Hormone Radioimmunoassay. ed 2. Academic Press, Orlando, FL1979: 77-100
        • Patel Y.C.
        • Rao K.
        • Reichlin S.
        Somtostatin in human cerebrospinal fluid.
        N Engl J Med. 1977; 296: 529-533
        • Pepper G.M.
        • Krieger D.T.
        Hypothalamic-pituitary-adrenal abnormalities in depression: Their possible relation to central mechanisms regulating ACTH release.
        in: Neurobiology of Mood Disorders. vol 1. Williams & Wilkins, Baltimore1984: 245-270
        • Peterfreund R.A.
        • Vale W.W.
        Muscarinic cholinergic stimulation of Somatostatin secretion from long term dispersed cell cultures of fetal rat hypothalamus: Inhibition by γ-aminobutyric acid and serotonin.
        Endocrinology. 1983; 112: 526-534
        • Peterfreund R.A.
        • Vale W.W.
        Somatostatin analogs inhibit Somatostatin secretion from cultured hypothalamus cells.
        Neuroendocrinology. 1984; 39: 397-402
        • Post R.M.
        • Ballenger J.C.
        • Uhde T.W.
        • Bunney W.E.
        Efficacy of carbamazepine in manicdepressive illness: Implications for underlying mechanisms.
        in: Neurobiology of Mood Disorders. vol 1. Williams & Wilkins, Baltimore1984: 777-816
        • Pugsley T.A.
        • Lipmann W.
        Effect of Somatostatin analogues and 17-alphadihydroequilin on rat brain opiate receptors.
        Res Commun Chem Pathol Pharmacol. 1978; 21: 153-156
        • Purdy R.E.
        • Julien R.M.
        • Fairhurst A.S.
        • Terry M.D.
        Effect of carbamazepine on the in vitro uptake and release of norepinephrine in adrenergic nerves of rabbit aorta and in whole brain synaptosomes.
        Epilepsia. 1977; 18: 251-257
        • Raskind M.
        • Perskind E.
        • Rivard M.F.
        • Veith R.
        • Barnes R.
        Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia.
        Am J Psychiatry. 1982; 139: 1468-1471
        • Reichlin S.
        Systems for the study of regulation of neuropeptide secretion.
        in: Martin J.B. Reichlin S. Bick K.L. Neurosecretion and Brain Peptides. Raven Press, New York1981: 573-597
        • Reichlin S.
        Somatostatin in the nervous system.
        in: Schmitt F.O. Bird S.J. Bloom F.E. Molecular Genetic Neuroscience. Raven Press, New York1982: 359-372
        • Reichlin S.
        Somatostatin.
        N Engl J Med. 1983; 309: 1495-1501
        • Reichlin S.
        Somatostatin.
        N Engl J Med. 1983; 309: 1556-1563
        • Reisine T.
        Somatostatin inhibition of cyclic AMP accumulation and adrenocorticotropin release: Mechanisms of action and mode of self-regulation.
        Clin Neuropharmacol. 1984; 7: 56-57
        • Renaud L.P.
        • Martin J.B.
        • Brazeau P.
        Depressant action of TRH, LH-RH and Somatostatin on activity of central neurons.
        Nature. 1975; 255: 233-235
        • Rezek M.
        • Havlicek V.
        • Hughes K.R.
        • Friesen H.
        Cortical administration of Somatostatin (SRIF): Effect on sleep and motor behavior.
        Pharmacol Biochem Behav. 1976; 5: 73-77
        • Rezek M.
        • Havlicek V.
        • Hughes K.R.
        • Friesen H.
        Central site of action of Somatostatin (SRIF): Role of hippocampus.
        Neuropharmacology. 1976; 15: 499-504
        • Rezek M.
        • Havlicek V.
        • Hughes K.R.
        • Friesen H.
        Behavioural and motor excitation and inhibition induced by the administration of small and large doses of Somatostatin into the amygdala.
        Neuropharmacology. 1977; 16: 157-162
        • Robbins R.J.
        • Sutton R.E.
        • Reichlin S.
        Effects of neurotransmitters and cyclic-AMP on somatostatin release from cultured cerebral cortical cells.
        Brain Res. 1982; 243: 377-386
        • Roberts G.W.
        • Crow T.J.
        • Polak J.M.
        Location of neuronal tangles in somatostatin neurones in Alzheimer's disease.
        Nature. 1985; 314: 92-94
        • Roy-Byrne P.
        • Joffe R.
        • Uhde T.W.
        • Post R.M.
        Effects of carbamazepine on thyroid function in affectively ill patients.
        Arch Gen Psychiatry. 1984; 41: 1150-1153
        • Rubinow D.R.
        • Gold P.W.
        • Post R.M.
        • Ballenger JC
        • Cowdry R
        • Bollinger J.
        • Reichlin S.
        CSF somatostatin in affective illness.
        Arch Gen Psychiatry. 1983; 40: 409-412
        • Rubinow D.R.
        • Gold P.W.
        • Post R.M.
        • Ballenger J.C.
        • Cowdry R.
        Somatostatin in patients with affective illness and in normal volunteers.
        in: Neurobiology of Mood Disorders. Vol 1. Williams & Wilkins, Baltimore1984: 369-387
        • Rubinow D.R.
        • Post R.M.
        • Gold P.W.
        • Ballenger J.C.
        • Reichlin S.
        Effects of carbamazepine on cerebrospinal fluid somatostatin.
        Psychopharmacology. 1985; 85: 210-213
        • Rubinow D.R.
        • Post R.M.
        • Gold P.W.
        • Uhde T.W.
        Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness.
        Psychopharmacology. 1986; (in press.)
        • Sachar E.J.
        • Hellman L.
        • Roffwarg H.P.
        • Halpern F.S.
        • Fukushima D.K.
        • Gallagher T.F.
        Disrupted 24-hour patterns of cortisol secretion in psychotic depression.
        Arch Gen Psychiatry. 1973; 28: 19-24
        • Sakanaka M.
        • Shiosaka S.
        • Takatsuki K.
        • Inagati S.
        • Takagi H.
        • Senba E.
        • Kawai Y.
        • Matsuzaki T.
        • Tohyama M.
        Experimental immunohistochemical studies on the amygdalofugal pepti dergic (substance P and somatostatin) fibers in the stria terminalis of the rat.
        Brain Res. 1981; 221: 231-242
        • Schildkraut J.J.
        • Orsulak P.J.
        • Schatzber A.F.
        • Rosenbaum A.H.
        Urinary MHPG in affective disorders.
        in: Neurobiology of Mood Disorders. Vol 1. Williams & Wilkins, Baltimore1984: 519-528
        • Schlegel W.
        • Wuarin F.
        • Wollheim C.B.
        • Zahnd G.R.
        Somatostatin lowers the cytosolic free Ca2+ concentration in clonal rat pituitary cells (GH3 cells).
        Cell Calcium. 1984; 5: 223-236
        • Schmechel D.E.
        • Vickrey B.G.
        • Fitzpatrick D.
        • Elde R.P.
        GABAergic neurons of mammalian cerebral cortex: Widespread subclass defined by somatostatin content.
        Neurosci Lett. 1984; 47: 227-232
        • Schonbrunn A.
        • Tashjian A.
        Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain.
        J Biol Chem. 1980; 255: 190-198
        • Schultzberg M.
        • Drefus C.F.
        • Gershon M.D.
        • Hokfelt T.
        • Elde R.P.
        • Nilsson G.
        • Said G.I.
        • Goldstein M.
        VIP, enkephalin, substance P and somatostatin-like immunoreactivity in neurons intrinsic to the intestine: Immunohistochemical evidence from organotypic tissue cultures.
        Brain Rex. 1978; 155: 239-248
        • Serby M.
        • Richardson S.B.
        • Twente S.
        • Siekierski J.
        • Rotrosen J.
        CSF somatostatin in Alz heimer's disease.
        in: Abstracts of the Annual Meeting of the American College of Neuropsychopharmacology, San Juan1983: 84
        • Shen L.-P.
        • Rutter W.J.
        Sequence of the human somatostatin 1 gene.
        Science. 1984; 224: 168-171
        • Sorensen K.V.
        • Christensen S.E.
        • Dupont E.
        • Hansen A.P.
        • Pedersen E.
        • Orskov H.
        Low so matostatin content in cerebrospinal fluid in multiple sclerosis.
        Acta Neurol Scand. 1980; 61: 186-191
        • Sorensen K.V.
        • Christensen S.E.
        • Hansen A.P.
        • Ingerslev J.
        • Pedersen E.
        • Orskov H.
        The origin of cerebrospinal fluid somatostatin: Hypothalamic or disperse central nervous system secretion.
        Neuroendocrinology. 1981; 32: 335-338
        • Spar J.E.
        • Gerner R.
        Does the dexamethasone suppression test distinguish dementia from depression?.
        Am J Psychiatry. 1982; 139: 238-240
        • Spitzer R.L.
        • Endicott J.
        • Robins E.
        Research Diagnostic Criteria: Rationale and reliability.
        Arch Gen Psychiatry. 1978; 35: 773-782
        • Srikant C.B.
        • Patel Y.C.
        Somatostatin receptors: Identification and characterization in rat brain membranes.
        in: Proc Natl Acad Sci USA. 78. 1981: 3930-3934
        • Srikant C.B.
        • Patel Y.C.
        Receptor binding of somatostatin-28 is tissue specific.
        Nature. 1981; 294: 259-260
        • Srikant C.B.
        • Patel Y.C.
        Somatostatin receptors.
        Adv Exp Med Biol. 1985; 188: 291-304
        • Tanaka S.
        • Tsujimoto A.
        Somatostatin facilitates the serotonin release from rat cerebral cortex, hippocampus and hypothalamic slices.
        Brain Res. 1981; 208: 219-222
        • Terenius L.
        Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors.
        Eur J Pharmacol. 1976; 38: 211-213
        • Terrence C.F.
        • Sax M.
        • Fromm G.H.
        • Chang C.H.
        • Yoo C.S.
        Effect of baclofen enantiomorphs on the spinal trigeminal nucleus and steric similarities of carbamazepine.
        Pharmacology. 1983; 27: 85-94
        • Tsujimoto A.
        • Shokichi T.
        Stimulatory effect of Somatostatin on norepinephrine release from rat brain cortex slices.
        Life Sci. 1980; 28: 903-910
        • Wehr T.A.
        Biological rhythms and manic-depressive illness.
        in: Neurobiology of Mood Disorder. Vol 1. Williams & Wilkins, Baltimore1984: 190-206
        • Weindl A.
        • Sofroniew M.V.
        Relation of neuropeptides to mammalian circumventricular organs.
        in: Martin J.B. Reichlin S. Bick K.L. Advances in Biochemical Psychopharmacology. Raven Press, New York1982: 303-320
        • Wood P.L.
        • Etienne P.
        • Lal S.
        • Gauthier S.
        • Cajal S.
        • Nair N.P.V.
        Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
        Life Sci. 1982; 31: 2073-2079